Sökning: WFRF:(Johnsson Hans) > Förbättrad strokepr...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03031naa a2200325 4500 | |
001 | oai:DiVA.org:oru-81107 | |
003 | SwePub | |
008 | 200408s2018 | |||||||||||000 ||swe| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-811072 URI |
040 | a (SwePub)oru | |
041 | a sweb eng | |
042 | 9 SwePub | |
072 | 7 | a vet2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hjemdahl, Paulu Karolinska universitetssjukhuset, Stockholm, Sweden4 aut |
245 | 1 0 | a Förbättrad strokeprevention vid förmaksflimmer med NOAK [Improved stroke prevention in atrial fibrillation: The stockholm experience of the introduction of NOACs] |
264 | 1 | b Läkartidningen AB,c 2018 |
338 | a print2 rdacarrier | |
520 | a The introduction of NOACs has put a focus on stroke prevention in atrial fibrillation (AF). The number of patients in Stockholm diagnosed with non-valvular AF increased from 41 008 in 2011 to 51 266 in 2017 and their treatment has been markedly improved. Between 2011 and 2017 total oral anticoagulant treatment increased from 51.6% (warfarin) to 77.3% (31% warfarin, 46.3% NOACs) and aspirin decreased from 31.6% to 7.2%. Treatment was especially improved among patients with CHA2DS2-VASc scores ≥2 and elderly high risk patients. We found an excellent persistence with OAC treatment (88% at 1 year and 83% at 2 years). A comparative effectiveness study showed that NOACs were at least as effective and safe as warfarin even among patients ≥80 years or with previous serious bleeds. After a gradual introduction of NOACs with many educational activities apixaban is now the first-line choice for stroke prevention in AF in Stockholm. Swedish guideline goals are fulfilled and outcomes are improved. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi0 (SwePub)303012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Health Care Service and Management, Health Policy and Services and Health Economy0 (SwePub)303012 hsv//eng |
700 | 1 | a Braunschweig, Friederu Karolinska universitetssjukhuset, Stockholm, Sweden4 aut |
700 | 1 | a Holmström, Margaretau Karolinska universitetssjukhuset, Stockholm, Sweden4 aut |
700 | 1 | a Johnsson, Hansu Karolinska universitetssjukhuset, Stockholm, Sweden4 aut |
700 | 1 | a von Euler, Mia,d 1967-u Karolinska universitetssjukhuset; KI:s strokeforskningsnätverk Södersjukhuset, Stockholm, Sweden4 aut0 (Swepub:oru)mavr |
700 | 1 | a Wallén, Håkanu Karolinska institutet; hjärtkliniken, Danderyds sjukhus, Stockholm, Sweden4 aut |
700 | 1 | a Forslund, Tomasu Karolinska institutet, Solna, Sweden4 aut |
710 | 2 | a Karolinska universitetssjukhuset, Stockholm, Swedenb Karolinska universitetssjukhuset; KI:s strokeforskningsnätverk Södersjukhuset, Stockholm, Sweden4 org |
773 | 0 | t Läkartidningend : Läkartidningen ABg 115:46q 115:46x 0023-7205x 1652-7518 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-81107 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy